Table: begin end state 1 31 cytoplasmic 32 52 transmembrane 53 62 non-cytoplasmic 63 86 transmembrane 87 97 cytoplasmic 98 117 transmembrane 118 121 non-cytoplasmic 122 146 transmembrane 147 166 cytoplasmic 167 188 transmembrane 189 197 non-cytoplasmic 198 217 transmembrane 218 259 cytoplasmic 260 278 transmembrane 279 297 non-cytoplasmic 298 316 transmembrane 317 326 cytoplasmic 327 346 transmembrane 347 351 non-cytoplasmic 352 375 transmembrane 376 386 cytoplasmic 387 411 transmembrane 412 416 non-cytoplasmic 417 438 transmembrane 439 500 cytoplasmic
Input: >BWI76_RS02250 MLKRKKVKPITLRDVTIIDDSKLKKAITAASLGNAMEWFDFGVYGFVAYALGKVFFPDAN PSVQMIAALGTFSVPFLIRPLGGLFFGMLGDKYGRQKILAITIVIMSISTFCIGLIPSYA TIGIWAPILLLLCKMAQGFSVGGEYTGASIFVAEYSPDRKRGFMGSWLDFGSIAGFVMGA GVVVLISSVVGEENFLSWGWRIPFFLALPLGIIGLYLRHALEETPAFQQHVDKMEQGDRE GLQEGPKVSFKEIATKHWRSLLTCIGLVISTNVTYYMLLTYMPSYLSHNLHYSEDHGVLI IIAIMVGMLFVQPVIGMLSDRFGRRPFILIGSVALFALSIPAFIMINSNVLGLIFAGLLV LAVVLNCFIGVMASSLPAMFPTHIRFSALASAFNISVLIAGLTPTLAAWLVESTQNLMMP AYYLMVIAVIGLITGLSMKETANRPLKGATPAASDIQEAKEILGEHYDNIEHKIEDIDQE IADLQEKRSRLVQQHPRIND
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server